<DOC>
	<DOCNO>NCT01356550</DOCNO>
	<brief_summary>This open-label , single-dose , parallel group study assess pharmacokinetics safety RO4917838 healthy volunteer patient mild , moderate severe chronic hepatic impairment . Patients healthy volunteer receive single oral dose RO4917838 .</brief_summary>
	<brief_title>A Study The Effect Hepatic Impairment The Pharmacokinetics RO4917838</brief_title>
	<detailed_description />
	<criteria>General : Body mass index ( BMI ) 18 32 kg/m2 inclusive Healthy Subjects : Adult male female subject , 1870 year age Hepatically impaired patient : Adult patient , 1865 year age Documented chronic stable mild/moderate/severe liver disease ( ChildPugh class A , B C ) Hepatic impairment primary must complication underlie primary disease General : Pregnant lactate woman Suspicion drug abuse addiction time screening/Day 1 history drug abuse last month ( patient ) last year ( healthy volunteer ) prior Day 1 Confirmed significant allergic reaction drug , multiple allergy judgement investigator Positive HIV infection Renal insufficiency Healthy volunteer : History significant disease , evidence disease condition could interfere study relapse immediately study Any history depressive episode treatment antidepressant Alcohol consumption average 2 unit ( 16 g ) alcohol females 3 unit ( 24 g ) male per day , positive alcohol breath test screening/Day 1 Positive hepatitis B and/or hepatitis C infection Hepatically impair patient : Evidence unstable clinically significant disease impair hepatic function , condition disease could interfere study relapse immediately study Episode acute depression within last 6 month current previous ( within last 6 month ) antidepressant treatment Hepatocellular carcinoma acute hepatic disease cause infection drug toxicity Presence surgically create transjugular intrahepatic portal systemic shunt Biliary liver cirrhosis cause hepatic impairment relate parenchyma disorder and/or disease liver</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>